eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Scientific Papers found: Click to Expand⟱
*antiOx↑, *eff?,
eff?, tumCV↓, TumCG↓, ROS↑, P53↑, CSCs↓, CD133↓, ALDH1A1↓, Nanog↓, SOX2↓, OCT4↓, CDK1↓, CaMKII
↓, STAT3↓, Akt↓, ERK↓,
*eff?, *Half-Life↝, *Inflam↓,
| - |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
GSH↓, Fenton↑, ROS↑, NO↑, sonoS↑, eff↑, NO↑, *toxicity∅, eff?,
eff↑, cardioP↑, eff?, PSA↓, RenoP↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Fenton↑, 1, GSH↓, 1, ROS↑, 2,
Cell Death ⓘ
Akt↓, 1,
Kinase & Signal Transduction ⓘ
CaMKII
↓, 1,
Transcription & Epigenetics ⓘ
sonoS↑, 1, tumCV↓, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
ALDH1A1↓, 1, CD133↓, 1, CSCs↓, 1, ERK↓, 1, Nanog↓, 1, OCT4↓, 1, SOX2↓, 1, STAT3↓, 1, TumCG↓, 1,
Angiogenesis & Vasculature ⓘ
NO↑, 2,
Immune & Inflammatory Signaling ⓘ
PSA↓, 1,
Drug Metabolism & Resistance ⓘ
eff?, 3, eff↑, 2,
Clinical Biomarkers ⓘ
PSA↓, 1,
Functional Outcomes ⓘ
cardioP↑, 1, RenoP↑, 1,
Total Targets: 25
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
eff?, 2, Half-Life↝, 1,
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 5
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid
Home Page